Pancreatic Cancer Research

ResearcherMedical University of LublinActive in the last 2 years

Magdalena Skórzewska

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5004-9940; OpenAlex author ID A5041657138. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Efficacy and Safety of Daraxonrasib (RMC-6236) in Previously Treated Metastatic RAS-Mutated Pancreatic Ductal Adenocarcinoma: A Systematic Review. Last author DOI 10.3390/cancers18193112↗
  2. Surgical treatment of pancreatic cancer. Co-author DOI 10.5604/01.3001.0011.7493↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Natalia Gierulska · 1 shared paper, 2026 · strength 0.39
  2. Wioletta Masiak · 1 shared paper, 2018 · strength 0.12
  3. Wojciech Piotr Polkowski · 1 shared paper, 2018 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.